Those are the types of clues Eli Lillys CEO, David Ricks, says his company will pursue next year, testing whether its GLP-1 drug, tirzepatide (called Mounjaro for diabetes treatment, and Zepbound for weight loss), could help with addiction to alcohol, nicotine, and other things we dont think about [as being] connected to weight. In comments he made in December, Ricks said the drugs might be anti-hedonicsmeaning they counteract our hedonistic pursuit of pleasure, be it from food, alcohol, or drugs
The Myers WayLeaky Gut Revive Smoothies & Drinks e-Book
Over half (56%) of GLP-1 users say they started making healthier food choices during treatment
If you've ever felt broken, defeated, or exhausted by dieting, this conversation offers a new path forwardone rooted in healing, hope, and finally feeling free
doi:10.5217/ir.2017.15.3.352 79